Vivos Therapeutics, Inc. (VVOS)
NASDAQ
Vivos Therapeutics, Inc. Long Term Debt 2019–2025
Vivos Therapeutics, Inc. annual long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Vivos Therapeutics, Inc. long term debt as of December 31, 2025: 753,000, a 40.47% decrease year-over-year.
- Vivos Therapeutics, Inc. long term debt for 2025 were 753,000, a 40.47% decrease from 2021.
- Vivos Therapeutics, Inc. long term debt for 2021 were 1.3M, a 1.94% decrease from 2020.
- Vivos Therapeutics, Inc. long term debt for 2020 were 1.3M, a 65.22% decrease from 2019.
- Vivos Therapeutics, Inc. long term debt for 2019 were 3.7M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Vivos Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $1 |
| 2021 | $1 |
| 2020 | $1 |
| 2019 | $4 |
Vivos Therapeutics, Inc. Long Term Debt — FAQ
Vivos Therapeutics, Inc. (VVOS) long term debt over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VVOS's long term debt history?
The chart and table above show Vivos Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.